ANVISA registration 10337990057Valid until Feb 18, 2036HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS
ANVISA Registration Number: 10337990057LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA.LEICA BIOSYSTEMS NEWCASTLE LTDRisk Class IV
Device names
- Technical name
- HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS
- Risk class
- Class IV
PT: HERPES VÍRUS (HHV 5) - CITOMEGALOVÍRUS
Registration details
- Registration Number
- 10337990057
- Process Number
- 25351151567202551
- CNPJ
- 52201456000113
Company information
- Registration Holder
- LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA.
- Manufacturer
- LEICA BIOSYSTEMS NEWCASTLE LTD
- Manufacturing Country
- United Kingdom
PT: REINO UNIDO
Dates and status
- Publication Date
- Feb 18, 2026
- Validity
- 18/02/2036
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10337990057 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD. The registration is held by LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA. with validity until Feb 18, 2036.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.